血栓摘出装置市場規模、シェア、成長分析：技術別、タイプ別、用途別、地域別 - 産業予測 2025～2032年

血栓摘出装置市場規模は2023年に20億米ドルと評価され、予測期間（2025-2032年）のCAGRは6.9%で、2024年の21億4,000万米ドルから2032年には36億5,000万米ドルに成長する見通しです。

血栓摘出装置の世界市場は、心血管疾患の有病率の上昇、技術の進歩、高齢化により大幅な成長が見込まれています。血栓除去のためのステントリトリーバー装置のような低侵襲技術の革新は、手技の合併症や回復時間を減少させながら、患者の転帰を著しく向上させています。高齢者人口が増加するにつれて、高齢者は心血管系の問題や血栓形成を起こしやすくなるため、効果的な血栓除去ソリューションに対する需要も増加しています。この人口動態の変化は、市場における高度な治療オプションの必要性を強調しています。その結果、米国の血栓摘出装置市場は、高齢化社会における重要な医療ニーズに対応し、今後の予測期間において一貫したCAGRで持続的な成長を遂げることになります。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析

血栓摘出装置市場規模：技術別& CAGR（2025-2032）

• 市場概要
• 機械的血栓除去術
• 吸引血栓除去術
• レオリティック血栓除去術

血栓摘出装置市場規模：タイプ別& CAGR（2025-2032）

• 市場概要
• 自動化デバイス
• 手動デバイス

血栓摘出装置市場規模：ユーティリティ別 & CAGR（2025-2032）

• 市場概要
• 再利用可能なデバイス
• 使い捨てデバイス

血栓摘出装置市場規模：用途別& CAGR（2025-2032）

• 市場概要
• 末梢疾患
• 冠動脈疾患
• 神経疾患

血栓摘出装置市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• Medtronic（Ireland）
• Abbott（United States）
• Boston Scientific（United States）
• Stryker（United States）
• Johnson & Johnson（United States）
• Penumbra（United States）
• Terumo（Japan）
• Koninklijke Philips（Netherlands）
• Becton, Dickinson and Company（BD）（United States）
• Merit Medical Systems（United States）
• Teleflex Incorporated（United States）
• AngioDynamics（United States）
• Edwards Lifesciences（United States）
• Cerenovus（United States）
• Vascular Solutions（United States）
• Balt Extrusion（United States）
• Acandis（Germany）

結論と提言

Thrombectomy Devices Market size was valued at USD 2.0 billion in 2023 and is poised to grow from USD 2.14 billion in 2024 to USD 3.65 billion by 2032, growing at a CAGR of 6.9% during the forecast period (2025-2032).

The global market for thrombectomy devices is poised for substantial growth due to the rising prevalence of cardiovascular diseases, technological advancements, and an aging population. Innovations in minimally invasive technologies, like stent retriever devices for clot removal, have significantly enhanced patient outcomes while decreasing procedural complications and recovery times. As the geriatric population expands, so does the demand for effective thrombectomy solutions, given that older adults are more prone to cardiovascular issues and blood clot formation. This demographic shift underscores the necessity for advanced treatment options in the market. Consequently, the U.S. thrombectomy devices market is set for sustainable growth at a consistent CAGR in the upcoming forecast period, addressing critical healthcare needs in an aging society.

Top-down and bottom-up approaches were used to estimate and validate the size of the Thrombectomy Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Thrombectomy Devices Market Segments Analysis

Global Thrombectomy Devices Market is segmented by Technology, Type, Utility, Application and region. Based on Technology, the market is segmented into Mechanical Thrombectomy, Aspiration Thrombectomy and Rheolytic Thrombectomy. Based on Type, the market is segmented into Automated Devices and Manual Devices. Based on Utility, the market is segmented into Reusable Devices and Disposable Devices. Based on Application, the market is segmented into Peripheral Diseases, Coronary Disease and Neural Diseases. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Thrombectomy Devices Market

The rising prevalence of cardiovascular diseases, such as strokes and heart attacks, is a major driving force behind the thrombectomy devices market. As more individuals age and adopt sedentary lifestyles, the incidence of these health issues continues to escalate. Thrombectomy devices are crucial for the rapid removal of blood clots, thereby restoring normal blood circulation and significantly improving patient outcomes. This increasing demand for effective treatment options highlights the importance of thrombectomy devices in modern medical practice, ultimately contributing to their growth within the healthcare industry. The combination of an aging population and lifestyle factors creates a pressing need for these innovative devices.

Restraints in the Thrombectomy Devices Market

The Thrombectomy Devices market faces certain restraints due to the inherent risks associated with thrombectomy procedures, much like other medical interventions. Complications such as vessel injury, bleeding, infection, or the risk of a clot becoming dislodged and leading to an embolism can arise. Such safety and efficacy concerns surrounding these devices may affect the choices made by both healthcare providers and patients, ultimately impacting the market's growth potential. These apprehensions regarding potential adverse outcomes could deter adoption rates, thereby posing challenges to the overall advancement and expansion of the thrombectomy devices market.

Market Trends of the Thrombectomy Devices Market

The Thrombectomy Devices market is experiencing a significant upward trend, driven by the increasing incidence of ischemic stroke, prompting heightened demand for sophisticated medical technologies. Key market players are intensifying their research and development initiatives to introduce innovative thrombectomy solutions, including advanced aspiration devices, clot retrievers, and specialized catheters. These devices are engineered with state-of-the-art technology that enhances tracking precision, facilitates seamless clot retrieval, and boasts user-friendly operations. As these advanced solutions become more accessible, healthcare professionals are better equipped to tackle the complexities of ischemic stroke treatment, ultimately leading to improved patient outcomes and a more resilient healthcare landscape.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Thrombectomy Devices Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Mechanical Thrombectomy
• Aspiration Thrombectomy
• Rheolytic Thrombectomy

Global Thrombectomy Devices Market Size by Type & CAGR (2025-2032)

• Market Overview
• Automated Devices
• Manual Devices

Global Thrombectomy Devices Market Size by Utility & CAGR (2025-2032)

• Market Overview
• Reusable Devices
• Disposable Devices

Global Thrombectomy Devices Market Size by Application & CAGR (2025-2032)

• Market Overview
• Peripheral Diseases
• Coronary Disease
• Neural Diseases

Global Thrombectomy Devices Market Size & CAGR (2025-2032)

• North America (Technology, Type, Utility, Application)
  • US
  • Canada
• Europe (Technology, Type, Utility, Application)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Technology, Type, Utility, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Technology, Type, Utility, Application)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Technology, Type, Utility, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Medtronic (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Penumbra (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke Philips (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD) (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merit Medical Systems (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teleflex Incorporated (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AngioDynamics (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Edwards Lifesciences (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cerenovus (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vascular Solutions (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Balt Extrusion (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Acandis (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations